메뉴 건너뛰기




Volumn 128, Issue 13, 2013, Pages 1462-1469

Population pharmacokinetics of enoxaparin during the antenatal period

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

EID: 84884670350     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.003198     Document Type: Conference Paper
Times cited : (44)

References (46)
  • 1
    • 77953594954 scopus 로고    scopus 로고
    • Drugs dispensed in primary care during pregnancy: A record-linkage analysis in Tayside Scotland
    • Irvine L, Flynn RW, Libby G, Crombie IK, Evans JM. Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. Drug Saf. 2010;33:593-604.
    • (2010) Drug Saf , vol.33 , pp. 593-604
    • Irvine, L.1    Flynn, R.W.2    Libby, G.3    Crombie, I.K.4    Evans, J.M.5
  • 2
    • 84865858101 scopus 로고    scopus 로고
    • Prescribing without evidence: Pregnancy
    • Thomas SH, Yates LM. Prescribing without evidence: pregnancy. Br J Clin Pharmacol. 2012;74:691-697.
    • (2012) Br J Clin Pharmacol , vol.74 , pp. 691-697
    • Thomas, S.H.1    Yates, L.M.2
  • 4
    • 0027043228 scopus 로고
    • Use of low molecular weight heparin for prophylaxis and treatment and treatment of thromboembolism in pregnancy
    • Gillis S, Shushan A, Eldor A. Use of low molecular weight heparin for prophylaxis and treatment and treatment of thromboembolism in pregnancy. Int J Gynaecol Obestet. 1992; 39: 297-301.
    • (1992) Int J Gynaecol Obestet , vol.39 , pp. 297-301
    • Gillis, S.1    Shushan, A.2    Eldor, A.3
  • 5
    • 22144466236 scopus 로고    scopus 로고
    • Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy
    • Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401-407.
    • (2005) Blood , vol.106 , pp. 401-407
    • Greer, I.A.1    Nelson-Piercy, C.2
  • 6
    • 84873558091 scopus 로고    scopus 로고
    • Anticoagulant therapy for venous thromboembolism during pregnancy: A systematic review and a meta-analysis of the literature
    • Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S, Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2013;11:270-281.
    • (2013) J Thromb Haemost , vol.11 , pp. 270-281
    • Romualdi, E.1    Dentali, F.2    Rancan, E.3    Squizzato, A.4    Steidl, L.5    Middeldorp, S.6    Ageno, W.7
  • 7
    • 49849101762 scopus 로고    scopus 로고
    • Where do we go now with LMWH use in obstetric care?
    • Patel JP, Hunt BJ. Where do we go now with LMWH use in obstetric care? J Thromb Haemost. 2008; 6: 1461-1467.
    • (2008) J Thromb Haemost , vol.6 , pp. 1461-1467
    • Patel, J.P.1    Hunt, B.J.2
  • 8
    • 25144516296 scopus 로고    scopus 로고
    • Pregnancy-induced changes in pharmacokinetics: A mechanistic-based approach
    • Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet. 2005;44:989-1008.
    • (2005) Clin Pharmacokinet , vol.44 , pp. 989-1008
    • Anderson, G.D.1
  • 10
    • 84856809942 scopus 로고    scopus 로고
    • VTE, thrombophilia, antithrombotic therapy and pregnancy: Antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Guidelines
    • Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy and pregnancy: antithrombotic therapy and prevention of thrombosis, American College of Chest Physicians Guidelines. Chest. 2012;141(suppl):e691s-e736s.
    • (2012) Chest , vol.141 , Issue.SUPPL.
    • Bates, S.M.1    Greer, I.A.2    Middeldorp, S.3    Veenstra, D.L.4    Prabulos, A.M.5    Vandvik, P.O.6
  • 11
    • 0028333023 scopus 로고
    • The use of low molecular weight heparin for thromboprophylaxis in pregnancy
    • Sturridge F, de Swiet M, Letsky E. The use of low molecular weight heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol. 1994;101:69-71.
    • (1994) Br J Obstet Gynaecol , vol.101 , pp. 69-71
    • Sturridge, F.1    De Swiet, M.2    Letsky, E.3
  • 13
    • 0030957087 scopus 로고    scopus 로고
    • Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
    • Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol. 1997;176: 1062-1068.
    • (1997) Am J Obstet Gynecol , vol.176 , pp. 1062-1068
    • Nelson-Piercy, C.1    Letsky, E.A.2    De Swiet, M.3
  • 15
    • 0032738711 scopus 로고    scopus 로고
    • Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy
    • Casele HL, Laifer SA, Woelkers DA, Venkataramanan R. Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol. 1999;181(pt 1):1113-1117.
    • (1999) Am J Obstet Gynecol , vol.181 , Issue.PART 1 , pp. 1113-1117
    • Casele, H.L.1    Laifer, S.A.2    Woelkers, D.A.3    Venkataramanan, R.4
  • 16
    • 0035083961 scopus 로고    scopus 로고
    • Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy
    • Bremme K, van Rooijen M, Yu A, Blombäck M. Accumulation of low molecular mass heparin during prophylactic treatment in pregnancy. Blood Coagul Fibrinolysis. 2001;12:149-155.
    • (2001) Blood Coagul Fibrinolysis , vol.12 , pp. 149-155
    • Bremme, K.1    Van Rooijen, M.2    Yu, A.3    Blombäck, M.4
  • 17
    • 0034655194 scopus 로고    scopus 로고
    • Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: A prospective cohort study
    • Crowther MA, Spitzer K, Julian J, Ginsberg J, Johnston M, Crowther R, Laskin C. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: a prospective cohort study. Thromb Res. 2000;98:133-138.
    • (2000) Thromb Res , vol.98 , pp. 133-138
    • Crowther, M.A.1    Spitzer, K.2    Julian, J.3    Ginsberg, J.4    Johnston, M.5    Crowther, R.6    Laskin, C.7
  • 18
    • 0033812190 scopus 로고    scopus 로고
    • Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy
    • Ellison J, Walker ID, Greer IA. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG. 2000;107:1116-1121.
    • (2000) BJOG , vol.107 , pp. 1116-1121
    • Ellison, J.1    Walker, I.D.2    Greer, I.A.3
  • 20
    • 14844328732 scopus 로고    scopus 로고
    • Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event
    • Hunt BJ, Gattens M, Khamashta M, Nelson-Piercy C, Almeida A. Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event. Blood Coagul Fibrinolysis. 2003;14:735-739.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 735-739
    • Hunt, B.J.1    Gattens, M.2    Khamashta, M.3    Nelson-Piercy, C.4    Almeida, A.5
  • 21
    • 0037331214 scopus 로고    scopus 로고
    • Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
    • Jacobsen AF, Qvigstad E, Sandset PM. Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy. BJOG. 2003;110:139-144.
    • (2003) BJOG , vol.110 , pp. 139-144
    • Jacobsen, A.F.1    Qvigstad, E.2    Sandset, P.M.3
  • 23
    • 6344241111 scopus 로고    scopus 로고
    • Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy: A pharmacokinetic study
    • Norris LA, Bonnar J, Smith MP, Steer PJ, Savidge G. Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy: a pharmacokinetic study. Thromb Haemost. 2004;92:791-796.
    • (2004) Thromb Haemost , vol.92 , pp. 791-796
    • Norris, L.A.1    Bonnar, J.2    Smith, M.P.3    Steer, P.J.4    Savidge, G.5
  • 24
    • 4444279681 scopus 로고    scopus 로고
    • Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy
    • Ensom MH, Stephenson MD. Pharmacokinetics of low molecular weight heparin and unfractionated heparin in pregnancy. J Soc Gynecol Investig. 2004;11:377-383.
    • (2004) J Soc Gynecol Investig , vol.11 , pp. 377-383
    • Ensom, M.H.1    Stephenson, M.D.2
  • 25
    • 17444380411 scopus 로고    scopus 로고
    • A protocol for the use of enoxaparin during pregnancy: Results from 85 pregnancies including 13 multiple gestation pregnancies
    • Huxtable LM, Tafreshi MJ, Ondreyco SM. A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies. Clin Appl Thromb Hemost. 2005;11:171-181.
    • (2005) Clin Appl Thromb Hemost , vol.11 , pp. 171-181
    • Huxtable, L.M.1    Tafreshi, M.J.2    Ondreyco, S.M.3
  • 26
    • 55449127268 scopus 로고    scopus 로고
    • Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis
    • Fox NS, Laughon SK, Bender SD, Saltzman DH, Rebarber A. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis. Obstet Gynecol. 2008;112:884-889.
    • (2008) Obstet Gynecol , vol.112 , pp. 884-889
    • Fox, N.S.1    Laughon, S.K.2    Bender, S.D.3    Saltzman, D.H.4    Rebarber, A.5
  • 28
    • 79955844576 scopus 로고    scopus 로고
    • Interpreting population pharmacokinetic-pharmacodynamic analyses: A clinical viewpoint
    • Duffull SB, Wright DF, Winter HR. Interpreting population pharmacokinetic-pharmacodynamic analyses: a clinical viewpoint. Br J Clin Pharmacol. 2011;71:807-814.
    • (2011) Br J Clin Pharmacol , vol.71 , pp. 807-814
    • Duffull, S.B.1    Wright, D.F.2    Winter, H.R.3
  • 29
    • 84862651945 scopus 로고    scopus 로고
    • Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women
    • van Hasselt JG, Green B, Morrish GA. Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women. Pharm Res. 2012;29:1609-1617.
    • (2012) Pharm Res , vol.29 , pp. 1609-1617
    • Van Hasselt, J.G.1    Green, B.2    Morrish, G.A.3
  • 31
    • 84884673733 scopus 로고    scopus 로고
    • European Medicines Agency Evaluation of Medicines for Human Use. Innovative drug development approaches: final report from the EMEA/CHMP Think Tank Group on Innovative Drug Development 2007 Accessed August 27, 2011
    • European Medicines Agency, Evaluation of Medicines for Human Use. Innovative drug development approaches: final report from the EMEA/CHMP Think Tank Group on Innovative Drug Development, 2007. http://www.ema.europa.eu/docs/ en-GB/document-library/Other/2009/10/WC500004913.pdf. Accessed August 27, 2011.
  • 32
    • 79955844576 scopus 로고    scopus 로고
    • Interpreting population pharmacokinetic-pharmacodynamic analyses: A clinical viewpoint
    • Duffull SB, Wright DF, Winter HR. Interpreting population pharmacokinetic-pharmacodynamic analyses: a clinical viewpoint. Br J Clin Pharmacol. 2011;71:807-814.
    • (2011) Br J Clin Pharmacol , vol.71 , pp. 807-814
    • Duffull, S.B.1    Wright, D.F.2    Winter, H.R.3
  • 33
    • 0021269554 scopus 로고
    • The population approach to pharmacokinetic data analysis: Rationale and standard data analysis methods
    • Sheiner LB. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev. 1984;15:153-171.
    • (1984) Drug Metab Rev , vol.15 , pp. 153-171
    • Sheiner, L.B.1
  • 34
    • 0025836658 scopus 로고
    • Population pharmacokinetics: Theory and practice
    • Aarons L. Population pharmacokinetics: theory and practice. Br J Clin Pharmacol. 1991;32:669-670.
    • (1991) Br J Clin Pharmacol , vol.32 , pp. 669-670
    • Aarons, L.1
  • 40
    • 72449195769 scopus 로고    scopus 로고
    • R Development Core Team. R: a language and environment for statistical computing
    • R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: A Foundation for Statistical Computing; 2006. (http://www.R-project.org).
    • (2006) Vienna Austria: A Foundation for Statistical Computing
  • 43
    • 35948961224 scopus 로고    scopus 로고
    • The management of antenatal venous thromboembolism in the UK and Ireland: A prospective multi-centre survey
    • Voke JM, Keidan J, Parvod S, Spencer NH, Hunt BJ. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multi-centre survey. Br J Haematol. 2007; 139: 545-558.
    • (2007) Br J Haematol , vol.139 , pp. 545-558
    • Voke, J.M.1    Keidan, J.2    Parvod, S.3    Spencer, N.H.4    Hunt, B.J.5
  • 44
    • 38949151562 scopus 로고    scopus 로고
    • Antenatal pulmonary embolism: Risk factors, management and outcomes
    • UKOSS
    • Knight M; UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008;115:453-461.
    • (2008) BJOG , vol.115 , pp. 453-461
    • Knight, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.